146 related articles for article (PubMed ID: 10942237)
1. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia.
Kini AR; Kay NE; Peterson LC
Leukemia; 2000 Aug; 14(8):1414-8. PubMed ID: 10942237
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia.
Wolowiec D; Wozniak Z; Potoczek S; Ganczarski G; Wrobel T; Kuliczkowski K; Frydecka I; Jeleń M
Anal Quant Cytol Histol; 2004 Oct; 26(5):263-70. PubMed ID: 15560532
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications.
Molica S
Leuk Lymphoma; 2001 Aug; 42(4):603-7. PubMed ID: 11697488
[TBL] [Abstract][Full Text] [Related]
4. Assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Antic D; Jovanovic MP; Fekete MD; Cokic V
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):353-6. PubMed ID: 20182346
[TBL] [Abstract][Full Text] [Related]
5. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
6. [Angiogenesis in the bone marrow of patients with chronic lymphocytic leukaemia].
Kasparová P; Smolej L
Cesk Patol; 2007 Apr; 43(2):50-8. PubMed ID: 17623976
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Jamroziak K; Szmigielska-Kaplon A; Krawczynska A; Lech-Maranda E; Wierzbowska A; Jesionek-Kupnicka D; Blonski JZ; Robak T
Leuk Lymphoma; 2009 Jan; 50(1):62-7. PubMed ID: 19125384
[TBL] [Abstract][Full Text] [Related]
8. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
Bairey O; Zimra Y; Shaklai M; Rabizadeh E
Br J Haematol; 2001 May; 113(2):400-6. PubMed ID: 11380405
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.
Molica S; Vacca A; Ribatti D; Cuneo A; Cavazzini F; Levato D; Vitelli G; Tucci L; Roccaro AM; Dammacco F
Blood; 2002 Nov; 100(9):3344-51. PubMed ID: 12384436
[TBL] [Abstract][Full Text] [Related]
11. B-cell chronic lymphocytic leukemia: correlation of clinical stages with angiogenic cytokine expression.
Ho CL; Phyliky RL; Li CY
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):154-60. PubMed ID: 16785782
[TBL] [Abstract][Full Text] [Related]
12. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.
Shanafelt TD; Kay NE
Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
[TBL] [Abstract][Full Text] [Related]
14. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract][Full Text] [Related]
15. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Kay NE; Bone ND; Tschumper RC; Howell KH; Geyer SM; Dewald GW; Hanson CA; Jelinek DF
Leukemia; 2002 May; 16(5):911-9. PubMed ID: 11986954
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.
Perez-Atayde AR; Sallan SE; Tedrow U; Connors S; Allred E; Folkman J
Am J Pathol; 1997 Mar; 150(3):815-21. PubMed ID: 9060819
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3.
Badoux X; Bueso-Ramos C; Harris D; Li P; Liu Z; Burger J; O'Brien S; Ferrajoli A; Keating MJ; Estrov Z
Hum Pathol; 2011 Dec; 42(12):1989-2000. PubMed ID: 21733558
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in B-chronic lymphocytic leukemia.
Kay NE; Jelinek DF; Peterson L
Leuk Res; 2001 Aug; 25(8):709-10. PubMed ID: 11397477
[No Abstract] [Full Text] [Related]
20. Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
Molica S; Montillo M; Ribatti D; Mirabelli R; Tedeschi A; Ricci F; Veronese S; Vacca A; Morra E
Haematologica; 2007 Oct; 92(10):1367-74. PubMed ID: 17768114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
